British Columbia Cancer Agency-Vancouver Centre

Vancouver V5Z 4E6

0 studies enrolling now · 3 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, HER2 Positive Breast Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed